🇺🇸 FDA
Patent

US 9340784

Methods and compositions for modulating alpha-1-antitrypsin expression

granted A61KA61K31/7115A61K31/712

Quick answer

US patent 9340784 (Methods and compositions for modulating alpha-1-antitrypsin expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ionis Pharmaceuticals, Inc.
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/7115, A61K31/712, A61K31/7125